FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

21,577 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 0
R2B: 0
R3: 578
R4: 19,982
R4B: 194
R5: 823
R6: 0

By Authority

none: 2,208
hl7: 19,367
national: 2

Start Prev Rows 8800 - 9000 Next

Package	Version	Identity	Name/Title	Status	Date	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.59.json	Ischemic Stroke Other	active	2021-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.60.json	Ischemic Stroke Other	active	2021-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.61.json	Antithrombotic Therapy Antiplatelet	active	2025-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.62.json	Antithrombotic Therapy for Ischemic Stroke	active	2021-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.63.json	Present On Admission is Yes or Exempt	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.64.json	Application of Venous Foot Pumps	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.65.json	Application of Intermittent Pneumatic Compression Devices	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.66.json	Application of Graduated Compression Stockings	active	2022-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.67.json	20 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.68.json	37 to 42 Plus Weeks Gestation	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.69.json	37 to 38 Weeks Gestation	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.70.json	20 to 42 Plus Weeks Gestation	active	2023-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.71.json	20 to 42 Plus Weeks Gestation	active	2025-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.72.json	37 to 42 Plus Weeks Gestation	active	2023-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.73.json	37 to 42 Plus Weeks Gestation	active	2023-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.74.json	37 to 38 Weeks Gestation	active	2023-03	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.75.json	37 to 38 Weeks Gestation	active	2023-03	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.76.json	History of Atrial Ablation	active	2022-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.77.json	Placenta Accreta Spectrum Previa or Vasa Previa	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.78.json	Placenta Previa	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.143.json	Observation Services	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.159.json	All Primary and Secondary Cancer	active	2023-03	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.161.json	All Primary and Secondary Cancer	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.163.json	Emergency Department Evaluation	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.164.json	Admit Inpatient	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.171.json	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.173.json	Sickle Cell Disease with and without Crisis SNOMED	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.174.json	Sickle Cell Disease with and without Crisis ICD	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.175.json	Sickle Cell Disease with and without Crisis	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.176.json	Opioid Medication Assisted Treatment (MAT) HCPCS	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.177.json	Opioid Medication Assisted Treatment (MAT)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.178.json	Cancer Related Pain ICD 10	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.179.json	Cancer Related Pain SNOMED	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.180.json	Cancer Related Pain	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.10.json	Care Experience Preferences at End of Life LOINC	active	2024-02	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.12.json	Healthcare Agent Ordinality	active	2020-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.14.json	ADIClauseTypeVS	active	2022-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.17.json	Preconditions for Treatment Preferences	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.22.json	Advance Directive Document Types	active	2024-07	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.23.json	AD Conditions and Prognosis Scenarios	active	2023-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.26.json	Healthcare Agent or Advisor Indicator	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.27.json	Initial Treatment portable medical order options	active	2024-08	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.28.json	Cardiopulmonary Resuscitation Order Options	active	2024-09	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.30.json	Cardiopulmonary Resuscitation Order Procedures	active	2024-08	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.31.json	Cardiopulmonary Resuscitation Procedures Grouping	active	2024-09	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.32.json	Additional Portable Medical Order Procedures	active	2025-04	hl7	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.33.json	Initial Treatment Portable Medical Order Procedures Grouping	active	2024-09	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.34.json	Additional portable medical order Procedures Grouping	active	2024-09	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.35.json	Medically Assisted Nutrition Order Options	active	2024-09	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.36.json	Medically Assisted Nutrition Portable Medical Order Procedures Grouping	active	2024-09	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.37.json	Healthcare Agent Powers	active	2024-11	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.38.json	Personal Health Goal Options LOINC	active	2025-03	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.40.json	Portable Medical Order Document Types	active	2025-04	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.41.json	Advance Healthcare Directive Document Types Grouper	active	2025-04	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.8.json	Treatment Intervention Preferences at End of Life LOINC	active	2025-04	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.1.json	Rituximab Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.100.json	Pathological M Stage M1c	active	2024-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.101.json	Pathological N Stage N3	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.102.json	N Stage pN1a	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.103.json	N Stage pN1b	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.105.json	Pathological N Stage pN1mi	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.106.json	Pathological N Stage N2b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.107.json	Pathological N Stage N2a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.108.json	Pathological N Stage N2	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.109.json	Pathological N Stage N1b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.110.json	Pathological N Stage N1a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.112.json	Pathological N Stage N0	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.114.json	Pathological T Stage T4d	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.115.json	Pathological T Stage T4c	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.116.json	Pathological T Stage T4b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.117.json	Pathological T Stage T4a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.118.json	Pathological T Stage T4	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.120.json	N Stage N2C	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.121.json	T Stage T3c	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.122.json	T Stage T3b	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.123.json	T Stage T3a	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.124.json	Pathological T Stage T3	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.125.json	T Stage T2c	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.126.json	T Stage T2b	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.127.json	T Stage T2a	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.128.json	Pathological T Stage T2	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.129.json	Pathological T Stage T1c	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.132.json	Pathological T Stage T1b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.135.json	Pathological T Stage T1a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.136.json	Pathological T Stage T1	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.137.json	Pathological T Stage T1mic	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.139.json	Pathological T Stage T0	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.142.json	Cancer Stage III	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.143.json	Cancer Stage IIIA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.144.json	Cancer Stage IIIB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.145.json	Cancer Stage IIIC	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.146.json	Cancer Stage IV	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.147.json	Cancer Stage IVA	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.148.json	Cancer Stage IVB	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.149.json	Cancer Stage IVC	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.151.json	Cisplatin Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.153.json	Vinorelbine Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.154.json	Gemcitabine Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.155.json	Docetaxel	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.156.json	Pemetrexed Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.158.json	Vinblastine Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.160.json	ECOG Performance Status	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.161.json	ECOG Performance Status	active	2020-10	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.162.json	ECOG Performance Status	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.164.json	Karnofsky Performance Status	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.165.json	Carboplatin Injectable	active	2020-09	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.166.json	Paclitaxel	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.168.json	Doxorubicin Injectable	active	2022-09	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.169.json	Irinotecan Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.179.json	Bevacizumab Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.181.json	Methotrexate	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.184.json	Breast Cancer	active	2022-06	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.185.json	Breast Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.191.json	Cancer Stage II	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.192.json	Cancer Stage IIA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.193.json	Cancer Stage IIB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.194.json	Pertuzumab Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.196.json	Ixabepilone Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.197.json	Goserelin	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.200.json	Epirubicin Injectable	active	2024-12	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.202.json	Ramucirumab Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.204.json	Letrozole	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.206.json	Exemestane	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.209.json	Fluorouracil	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.210.json	Capecitabine Oral	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.222.json	Aprepitant Oral	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.223.json	Fosaprepitant Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.255.json	Colorectal Cancer	active	2021-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.256.json	Colorectal Cancer	active	2021-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.257.json	Colorectal Cancer Chemotherapy	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.280.json	Cancer Stage IA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.281.json	Cancer Stage IB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.286.json	Cancer Stage IIC	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.291.json	Positive Result	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.292.json	Negative Result	active	2015-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.300.json	Pathological N Stage N1C	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.332.json	Daunorubicin Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.336.json	Palonosetron Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.341.json	External Beam Radiotherapy	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.349.json	Metastatic Cancer	active	2023-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.439.json	T Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.440.json	N Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.441.json	M Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.442.json	TNM Stage Group	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.449.json	Opioids	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.492.json	Pharmacological interventions for depression	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.535.json	Ovarian Cancer	active	2023-05	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.536.json	Ovarian Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.537.json	Fallopian Tube Cancer	active	2022-06	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.539.json	Fallopian Tube Cancer	active	2022-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.541.json	Peritoneal Cancer	active	2022-06	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.542.json	Peritoneal Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.547.json	Cancer Stage 1C	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.555.json	Gender Female	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.556.json	Gender Male	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.557.json	Pathological N Stage N3a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.558.json	Pathological N Stage N3b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.560.json	Rolapitant Oral	active	2024-07	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.599.json	Obinutuzumab Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.600.json	Ofatumumab Injectable	active	2024-12	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.602.json	Neurokinin 1 Receptor Antagonist	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.604.json	Serotonin Receptor Antagonist	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.61.json	Cetuximab Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.63.json	Panitumumab Injectable	active	2024-12	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.81.json	Palonosetron Oral	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.88.json	Lung Cancer	active	2015-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.89.json	Lung Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.95.json	M Stage M0	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.97.json	Pathological M Stage M1	active	2024-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.98.json	Pathological M Stage M1a	active	2024-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.99.json	Pathological M Stage M1b	active	2024-08	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1125.7.json	PROMIS Depression Assessment	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.11.json	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.13.json	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.15.json	Body Temperature	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.16.json	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.17.json	Abdominal Distension	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.18.json	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.19.json	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.20.json	Clostridium difficile infection	active	2019-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.3.json	Radiation Therapy Indicators from CPT	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.4.json	Diagnostic Radiology Surrounding Face and Sinus	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.5.json	Ear Surgery Affecting the Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.6.json	Allergic Rhinitis Immunotherapy	active	2017-06	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.8.json	Radiology to Head and Sinus	active	2017-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.9.json	Immunotherapy For Allergic Rhinitis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1136.63.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2024-07	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.1.json	C2S Alcohol Use Disorders	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.11.json	C2S Amphetamine Use Disorders	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.12.json	C2S Cannabis Use Disorders	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.13.json	C2S Cannabis Use Disorders	active	2016-09	hl7	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.14.json	C2S Cannabis Use Disorders	active	2016-09	hl7	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.15.json	C2S Cannabis Use DIsorders	active	2016-09	hl7	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.16.json	C2S Cocaine Use Disorder	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.17.json	C2S Cocaine Use Disorder	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.18.json	C2S Cocaine Use Disorder	active	2016-09	hl7	8
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.19.json	C2S Hallucinogens	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.2.json	C2S Alcohol Use Disorders	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.20.json	C2S Hallucinogens	active	2016-09	hl7	5
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.21.json	C2S Hallucinogens	active	2016-09	hl7	5